Cargando…
Effects of glycol-split low molecular weight heparin on placental, endothelial, and anti-inflammatory pathways relevant to preeclampsia
Low molecular weight heparin (LMWH) is being investigated as a potential preventative therapy against preeclampsia. There is evidence suggesting that LMWH may prevent preeclampsia through anticoagulation-independent mechanisms. In this study, we compared the in vitro placental, endothelial, and anti...
Autores principales: | Wat, Jovian M, Hawrylyshyn, Krista, Baczyk, Dora, Greig, Iain R, Kingdom, John C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297285/ https://www.ncbi.nlm.nih.gov/pubmed/29860275 http://dx.doi.org/10.1093/biolre/ioy127 |
Ejemplares similares
-
The antithrombin binding regions of heparin mediate fetal growth and reduced placental damage in the RUPP model of preeclampsia(†)
por: Wat, Jovian M, et al.
Publicado: (2020) -
Endothelial Dysfunction in Severe Preeclampsia is Mediated by Soluble Factors, Rather than Extracellular Vesicles
por: O’Brien, Michelle, et al.
Publicado: (2017) -
SUMO-4: A novel functional candidate in the human placental protein SUMOylation machinery
por: Baczyk, Dora, et al.
Publicado: (2017) -
Spatiotemporal distribution of small ubiquitin‐like modifiers during human placental development and in response to oxidative and inflammatory stress
por: Baczyk, Dora, et al.
Publicado: (2018) -
Rosiglitazone blocks first trimester in-vitro placental injury caused by NF-κB-mediated inflammation
por: Kadam, Leena, et al.
Publicado: (2019)